FEMCHECK
Live / Registered — Registered (as of 02 Nov 2021)
What this means for you
Registered since 02 Nov 2021. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79299178
- Registration number
- 6541669
- Mark type
- Stylized text
- Filed
- 26 May 2020
- Published for opposition
- 17 Aug 2021
- Registered
- 02 Nov 2021
- Attorney of record
- Kazuyo Morita
Goods and services
- Class 005 — Pharmaceuticals: Non-prescription, over the counter, diagnostic in vitro test kits for home use in the field of fertility monitoring, namely kits comprised of medical diagnostic reagents and assays to monitor urinary metabolites in particular estrogen metabolites, progesterone metabolites, cortisol metabolites and testosterone metabolites, and to quantitate urinary based assays to monitor ovulation and ovarian activity, to identify ovulation dates and to identify fertility periods of females; chemical diagnostic reagents and assays for medical purposes for use in diagnostic in vitro test kits for home use in the field of fertility monitoring, namely medical diagnostic reagents and assays to monitor urinary metabolites in particular estrogen metabolites, progesterone metabolites, cortisol metabolites and testosterone metabolites, to track ovulation and ovarian activity, to identify ovulation dates and to identify fertility periods of females
- Class 009 — Scientific and electric apparatus: Downloadable software and downloadable mobile applications for use with non-prescription, over the counter, diagnostic in vitro test kits for home use in the field of fertility monitoring in particular with kits comprised of medical diagnostic reagents and assays to monitor urinary metabolites in particular estrogen metabolites, progesterone metabolites, cortisol metabolites and testosterone metabolites, and to quantitate urinary based assays to monitor ovulation and ovarian activity, to identify ovulation dates and to identify fertility periods of females; Downloadable software and downloadable mobile applications for testing and tracking urinary metabolites, in particular estrogen metabolites, progesterone metabolites, cortisol metabolites and testosterone metabolites, to monitor ovulation and ovarian activity, to identify ovulation dates and to identify fertility periods of females
- Class 035 — Advertising and business services: Retail and wholesale store services for non-prescription, over the counter, diagnostic in vitro test kits for home use in the field of fertility monitoring, namely kits comprised of medical diagnostic reagents and assays to monitor urinary metabolites in particular estrogen metabolites, progesterone metabolites, cortisol metabolites and testosterone metabolites, and to quantitate urinary based assays to monitor ovulation and ovarian activity, to identify ovulation dates and to identify fertility periods of females; retail and wholesale store services for chemical diagnostic reagents and assays for medical purposes for use in diagnostic in vitro test kits for home use in the field of fertility monitoring, namely medical diagnostic reagents and assays to monitor urinary metabolites in particular estrogen metabolites, progesterone metabolites, cortisol metabolites and testosterone metabolites, to track ovulation and ovarian activity, to identify ovulation dates and to identify fertility periods of females; retail and wholesale store services for downloadable software and downloadable mobile applications for use with non-prescription, over the counter, diagnostic in vitro test kits for home use in the field of fertility monitoring, namely kits comprised of medical diagnostic reagents and assays to monitor urinary metabolites in particular estrogen metabolites, progesterone metabolites, cortisol metabolites and testosterone metabolites, and to quantitate urinary based assays to monitor ovulation and ovarian activity, to identify ovulation dates and to identify fertility periods of females; retail and wholesale store services for downloadable software and downloadable mobile applications for testing and tracking urinary metabolites, in particular estrogen metabolites, progesterone metabolites, cortisol metabolites and testosterone metabolites, to monitor ovulation and ovarian activity, to identify ovulation dates and to identify fertility periods of females; retail and wholesale store services for software as a service (SAAS) services featuring software for use with non-prescription, over the counter, diagnostic in vitro test kits for home use in the field of fertility monitoring, namely kits comprised of medical diagnostic reagents and assays to monitor urinary metabolites in particular estrogen metabolites, progesterone metabolites, cortisol metabolites and testosterone metabolites, and to quantitate urinary based assays to monitor ovulation and ovarian activity, to identify ovulation dates and to identify fertility periods of females; retail and wholesale store services for software as a service (SAAS) services for testing and tracking urinary metabolites, in particular estrogen metabolites, progesterone metabolites, cortisol metabolites and testosterone metabolites, to monitor ovulation and ovarian activity, to identify ovulation dates and to identify fertility periods of females; online advertising and marketing services in relation to the aforementioned goods
- Class 042 — Scientific and technological services: Software as a service (SAAS) services featuring software for use with non-prescription, over the counter, diagnostic in vitro test kits for home use in the field of fertility monitoring in particular with kits comprised of medical diagnostic reagents and assays to monitor urinary metabolites in particular estrogen metabolites, progesterone metabolites, cortisol metabolites and testosterone metabolites, and to quantitate urinary based assays to monitor ovulation and ovarian activity, to identify ovulation dates and to identify fertility periods of females; software as a service (SAAS) services featuring software for testing and tracking urinary metabolites, in particular estrogen metabolites, progesterone metabolites, cortisol metabolites and testosterone metabolites, to monitor ovulation and ovarian activity, to identify ovulation dates and to identify fertility periods of females; providing temporary use of online non-downloadable computer software for use with non-prescription, over the counter, diagnostic in vitro test kits for home use in the field of fertility monitoring in particular with kits comprised of medical diagnostic reagents and assays to monitor urinary metabolites in particular estrogen metabolites, progesterone metabolites, cortisol metabolites and testosterone metabolites, and to quantitate urinary based assays to monitor ovulation and ovarian activity, to identify ovulation dates and to identify fertility periods of females; providing temporary use of online non-downloadable computer software for testing and tracking urinary metabolites, in particular estrogen metabolites, progesterone metabolites, cortisol metabolites and testosterone metabolites, to monitor ovulation and ovarian activity, to identify ovulation dates and to identify fertility periods of females
Owner
- SCIENCE HAVEN LIMITED, Palmerston North, NZ
- SCIENCE HAVEN LIMITED, Palmerston North, NZ
- SCIENCE HAVEN LIMITED, Palmerston North, NZ
Prosecution history
- 16 May 2022 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 22 Apr 2022 — FINAL DISPOSITION NOTICE SENT TO IB
- 22 Apr 2022 — FINAL DISPOSITION PROCESSED
- 02 Feb 2022 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 02 Nov 2021 — REGISTERED-PRINCIPAL REGISTER
- 17 Aug 2021 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 17 Aug 2021 — PUBLISHED FOR OPPOSITION
- 15 Aug 2021 — NOTIFICATION PROCESSED BY IB
- 28 Jul 2021 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 28 Jul 2021 — NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
- 28 Jul 2021 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 13 Jul 2021 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 13 Jul 2021 — EXAMINER'S AMENDMENT ENTERED
- 13 Jul 2021 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 13 Jul 2021 — EXAMINERS AMENDMENT E-MAILED